To obtain usable level of purified ACT, samples from AD or control were pooled; plasma samples showing comparable levels of this serpin, as assessed by competitive ELISA, i.e. moderately high ACT levels, were chosen. The gene discussed is SERPINA3; the disease is Alzheimer disease.